Literature DB >> 1881548

MRI of subarachnoid dissemination of medulloblastoma.

M Kochi1, Y Mihara, A Takada, C Yatomi, M Morioka, S Yamashiro, S Yano, J Kuratsu, S Uemura, Y Ushio.   

Abstract

We report two cases with subarachnoid dissemination of medulloblastoma depicted clearly by Gadolinium-DTPA enhanced MRI. We also demonstrate the superiority of Gadolinium-DTPA enhanced MRI over nonenhanced MRI, CT, myelography and postmyelographic CT for diagnosing subarachnoid dissemination and for monitoring the response to therapy.

Entities:  

Mesh：

Year:  1991        PMID： 1881548     DOI： 10.1007/bf00588233

Source DB:  PubMed          Journal:  Neuroradiology        ISSN： 0028-3940            Impact factor:   2.804


  32 in total

1.  Prognosis and long-term follow-up in patients with medulloblastoma.

Authors:  M Choux; G Lena; J Hassoun
Journal:  Clin Neurosurg       Date:  1983

2.  Nuclear magnetic resonance (NMR) imaging of tumors in the posterior fossa.

Authors:  B D McGinnis; T J Brady; P F New; F S Buonanno; I L Pykett; R L DeLaPaz; J P Kistler; J M Taveras
Journal:  J Comput Assist Tomogr       Date:  1983-08       Impact factor: 1.826

3.  Radiation treatment for medulloblastoma. A 21-year review.

Authors:  M P Berry; R D Jenkin; C W Keen; B D Nair; W J Simpson
Journal:  J Neurosurg       Date:  1981-07       Impact factor: 5.115

4.  Gadolinium-DTPA as a contrast agent in MRI: initial clinical experience in 20 patients.

Authors:  D H Carr; J Brown; G M Bydder; R E Steiner; H J Weinmann; U Speck; A S Hall; I R Young
Journal:  AJR Am J Roentgenol       Date:  1984-08       Impact factor: 3.959

5.  Clinical NMR imaging of the brain: 140 cases.

Authors:  G M Bydder; R E Steiner; I R Young; A S Hall; D J Thomas; J Marshall; C A Pallis; N J Legg
Journal:  AJR Am J Roentgenol       Date:  1982-08       Impact factor: 3.959

6.  [The effect of Gd-DTPA on magnetic resonance imaging: a potential blood-brain barrier indicator].

Authors:  K Hashimoto; S Yamagata; J Minamikawa; Y Watanabe; M Kanesiro; H Kikuchi
Journal:  No To Shinkei       Date:  1988-05

7.  Leptomeningeal metastasis: MR imaging.

Authors:  P C Davis; N C Friedman; S M Fry; J A Malko; J C Hoffmann; I F Braun
Journal:  Radiology       Date:  1987-05       Impact factor: 11.105

8.  Cerebellar medulloblastoma: the importance of posterior fossa dose to survival and patterns of failure.

Authors:  C L Silverman; J R Simpson
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-11       Impact factor: 7.038

9.  Dyke Award. Evaluation of contrast-enhanced MR imaging in a brain-abscess model.

Authors:  V M Runge; J A Clanton; A C Price; W A Herzer; J H Allen; C L Partain; A E James
Journal:  AJNR Am J Neuroradiol       Date:  1985 Mar-Apr       Impact factor: 3.825

10.  [Changes in tissue T1 of brain tumor following GD-DTPA administration--differences in T1 time course and tissue-blood ratio by histological types].

Authors:  K Yoshida; M Furuse; Y Kaneoke; K Sasou; Y Motegi
Journal:  No To Shinkei       Date:  1988-06
View more
  3 in total

Review 1.  Intra-axial brain tumours.

Authors:  G Wilms; Ph Demaerel; S Sunaert
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 5.315

2.  Postoperative evaluation for disseminated medulloblastoma involving the spine: contrast-enhanced MR findings, CSF cytologic analysis, timing of disease occurrence, and patient outcomes.

Authors:  S P Meyers; S L Wildenhain; J K Chang; E C Bourekas; P F Beattie; D N Korones; D Davis; I F Pollack; R A Zimmerman
Journal:  AJNR Am J Neuroradiol       Date:  2000-10       Impact factor: 3.825

3.  MR imaging of skeletal metastases from medulloblastoma.

Authors:  P R Algra; T Postma; C J Van Groeningen; P Van der Valk; J L Bloem; J Valk
Journal:  Skeletal Radiol       Date:  1992       Impact factor: 2.199
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.